NS Wind Down Co., Inc.
DelistedCIK 1401708fmd_1E3PATKRCD8NEGVAJ3QF6G896QManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2011 to Sep 30, 2023, 48 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 31 | 48 | 63 | 86 | 115 | 107 | 126 | 117 | 145 | 127 |
| Cost of revenue | 15 | 21 | 26 | 30 | 32 | 36 | 44 | 52 | 68 | 65 |
| Gross profit | 16 | 26 | 37 | 56 | 83 | 70 | 82 | 65 | 77 | 62 |
| Research and development | 15 | 21 | 25 | 35 | 47 | 62 | 68 | 63 | 70 | 71 |
| Selling, general and administrative | 30 | 51 | 53 | 63 | 74 | 78 | 96 | 90 | 116 | 143 |
| Operating income | (28) | (46) | (41) | (41) | (38) | (69) | (83) | (88) | (108) | (152) |
| Interest expense | 2 | – | – | – | – | – | – | 15 | 8 | 8 |
| Interest and investment income | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 2 | 1 | 2 |
| Other non-operating income (expense) | (1) | (4) | (4) | (6) | (5) | (8) | 42 | (22) | (7) | (7) |
| Income before taxes | (29) | (50) | (45) | (47) | (43) | (77) | (40) | (110) | (115) | (159) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (29) | (50) | (46) | (47) | (44) | (77) | (41) | (110) | (115) | (160) |
| Net income | (29) | (50) | (46) | (47) | (44) | (77) | (41) | (110) | (115) | (160) |
| Net income to common shareholders | (34) | (50) | (46) | – | – | – | – | – | – | – |